Skip to main content
Business

Roundup Settlement: Who Qualifies and How Payouts Work

The Roundup settlement won final approval. See who qualifies, how the $10,000 to $165,000 payouts are calculated, and the claim deadlines you must not miss.

Marcus Vance
November 22, 202610 min read
Share
Roundup Settlement: Who Qualifies and How Payouts Work
Table of contents

You sprayed weedkiller along a fence line every summer for twenty years. Or you mowed and treated golf courses for a living. Then a doctor said the words non-Hodgkin lymphoma, and somewhere along the way you heard that Roundup might be involved.

On Friday, November 20, a Missouri judge gave final approval to the Roundup settlement, a deal under which Bayer will pay up to $7.25 billion over about two decades to resolve current and future cancer claims. NPR reported that individual payments range from about $10,000 to $165,000. Where you land in that range depends on a handful of facts about your life, and most of them were fixed long before you ever heard of a class action.

Here is how the deal works, who qualifies, how payouts are calculated, and when money moves.

What the Roundup Settlement Actually Approved

St. Louis Circuit Judge Timothy Boyer signed the written judgment on November 20, according to the Associated Press. He called the average payouts "fair and adequate" and described the total as among the largest mass tort personal-injury class settlements on record.

The money does not arrive as one check. Bayer pays into a special fund every year for up to 21 years, and claims are paid out of that fund. Bayer had already deposited $500 million within 10 business days of the judge's preliminary approval in March, as DTN/Progressive Farmer reported at the time.

The deal sits on top of a long legal bill. The AP reports Bayer had already set aside $16 billion for Roundup litigation, and NPR notes an earlier round of settlements cost about $10 billion to $11 billion and resolved more than 100,000 claims. Around 200,000 Roundup-related claims have been filed against the company in total.

Why Bayer wanted a class deal now

In June, the U.S. Supreme Court ruled that state courts cannot hold Bayer liable for failing to put a cancer warning on Roundup, because federal labeling rules do not require one. That ruling cut off the main legal theory behind many lawsuits. In October, a Missouri jury sided with Bayer in the first Roundup trial after the decision.

Both sides had reasons to settle. Bayer gets predictability. Plaintiffs get a guaranteed payment instead of a trial they might now lose. Bayer still denies that Roundup causes cancer, and the EPA has said glyphosate is not likely to cause cancer when used as directed, even though the World Health Organization's cancer agency classified it as "probably carcinogenic" in 2015.

How a Mass-Tort Class Settlement Works

A normal lawsuit is one person against one company. A mass tort is thousands of people claiming the same product hurt them, each with a different injury. A class settlement folds all of those people into one group, and a judge decides whether the deal is fair to the group as a whole.

The process follows a fixed sequence:

  1. Proposal. Bayer and class counsel filed the deal in Missouri state court in February.
  2. Preliminary approval. The judge allowed notice to go out in March.
  3. Notice and opt-out. Class members had 90 days, ending June 4, to opt out or object.
  4. Fairness hearing. The court heard objections at a hearing in September.
  5. Final approval. Granted November 20. Appeals can still follow.

The opt-out step is the one that matters most and has already passed. If you did not opt out, you are bound by the deal. You can no longer bring your own lawsuit over a qualifying cancer, and your compensation comes from the claims program instead.

The part that covers people who are not sick yet

This settlement is unusual because it binds future claimants. The AP and Farm Policy News both report it covers people who were exposed before February 17 and are diagnosed later. Critics see this as its weakest point. Gerson Smoger, a plaintiffs' lawyer, called it "the scariest, worst future settlement that's ever been contemplated," the AP reported. Supporters say future claimants now get a guaranteed path to payment the Supreme Court ruling had largely closed.

Who Qualifies for the Roundup Settlement

You are likely a class member if all of these apply, based on the class notice terms reported by The Hill and the AP:

  • You were exposed to Roundup or another glyphosate-based weedkiller before February 17, at work or at home.
  • You are a U.S. resident.
  • You have non-Hodgkin lymphoma, or you are diagnosed with it later. Some related cancers whose names include "lymphoma" or "lymphocytic" are also covered, according to The Hill.

You do not need a diagnosis to be in the class. You do need one to file a claim. Family members can file for a relative, including one who has died, and immigration status does not affect eligibility, The Hill reported.

Deadlines you cannot miss

Timing depends on when you were diagnosed. If your diagnosis came on or before March 4, The Hill reports you must register with a claim form within 180 days of final approval. Counting from November 20, that window closes in mid-May. If you are diagnosed in the future, you file within six years of the diagnosis and before the fund's last annual payment.

Miss the window and your award is zero. That rule catches more people than any eligibility test.

How Roundup Settlement Payouts Are Calculated

Awards are not equal. Claimants are sorted into nine tiers, The Hill reported, based on three facts: how you were exposed, how old you were at diagnosis, and whether your lymphoma is fast- or slow-growing. Within a tier, your score moves up or down with your treatment, how well you can prove exposure, how long and how often you used the product, and other medical conditions.

The AP gave three anchor points from the proposal:

  • About $165,000 on average for an agricultural, industrial or turf worker with long exposure, an aggressive form, and a diagnosis before age 60.
  • About $20,000 on average for a residential user with a less aggressive form, diagnosed between 60 and 77.
  • About $10,000 on average for anyone diagnosed at 78 or older.

Work exposure carries the most weight. To count as occupational, The Hill reports you need more than 80 hours of use on the job, at a job that provided more than half your annual income, backed by employment, payroll or tax records.

A worked example: three claimants, three outcomes

Take three people with the same diagnosis.

Maria, 54, has run a landscaping crew for 25 years and has payroll records showing it. Her lymphoma is aggressive. She sits in the top tier, where The Hill puts occupational payments at $60,000 to $165,000, and her paperwork pushes her toward the upper end.

Tom, 68, sprayed his own driveway and garden for decades. His cancer is slow-growing. He falls in a residential tier with an average near $20,000, and The Hill reports residential averages range from $20,000 to $40,000.

Ruth, 79, used the product the same way Tom did. Because of her age at diagnosis alone, she lands in tier nine with an average of about $10,000. Same exposure as Tom, half the money.

When the Money Arrives: Quick Pay Versus Program Awards

Lower tiers get a choice. The Hill reports that people in tiers five through nine, generally home users and anyone diagnosed at 78 or older, can take a quick pay amount, paid first-in, first-out. It is smaller but faster.

The trade looks like this:

  • Residential claimant: average program award of $20,000 to $40,000, or $7,700 to $14,500 through quick pay.
  • Diagnosed at 78 or older: average of $10,000, or $6,000 through quick pay.

Program awards are paid as Bayer makes its annual deposits, and The Hill reports they may rise with inflation after the fifth year. If you are weighing the two, run the gap through an inflation calculator to see what a payment five years out is worth in today's money. A $30,000 award that arrives late can still beat $11,000 now, but not by as much as the headline numbers suggest, and your age and health change that math.

What could still slow things down

Final approval is not the end. Objectors can appeal, and the AP notes the decision could be challenged. Earlier this year, objectors tried twice to move the case into federal court and lost both times. A new appeal would not void the deal, but it can delay payments.

What This Means If You Used Roundup

If you were diagnosed with non-Hodgkin lymphoma, gather records now: diagnosis date, treatment history, and anything that proves exposure, such as job records, purchase receipts or employer statements. Then file through the official settlement administrator, not a third party offering to "find" your money for a fee.

If you were exposed but are not sick, there is nothing to file today. Keep your exposure records somewhere you will find them, because a future claim will need them and the program runs for up to two decades.

If you hired a lawyer before the deal, your award comes out of the same matrix, and your fee agreement decides what share the lawyer keeps. Get that figure in writing. This works the same way as other big class deals, such as the Visa and Mastercard settlement for small merchants, where the claim form, not the headline total, decides what each person receives.

Frequently Asked Questions

Who qualifies for the Roundup settlement?

U.S. residents exposed to Roundup or another glyphosate weedkiller before February 17 who have, or are later diagnosed with, non-Hodgkin lymphoma or certain related lymphomas. Family members can file for a relative who has died.

How much will I get from the Roundup settlement?

Average awards range from about $10,000 to $165,000. The amount depends on whether exposure was at work or home, your age at diagnosis, and whether the cancer is aggressive. Workers diagnosed before 60 receive the most.

When will Roundup settlement payments start?

Quick pay awards for lower tiers move first. Larger program awards are paid as Bayer makes annual deposits over up to 21 years. Any appeal of the November 20 approval could delay payments.

Can I still sue Bayer over Roundup?

Only if you opted out before the June 4 deadline. Class members who stayed in are bound by the settlement, though one with a valid claim who is unpaid after five years can exit and regain the right to sue.

Do I need a diagnosis to be part of the Roundup class action?

No. Exposure before February 17 makes you a class member. You need a diagnosis only to file a claim, and future claimants have six years from diagnosis to do so.

The Settlement Is Approved. Your Claim Is Not Automatic.

The $7.25 billion figure is the ceiling on what Bayer pays over two decades, not a pool split evenly among everyone who ever sprayed a weed. Your share is set by records you can produce and deadlines you have to meet. If someone in your family used Roundup heavily and has lymphoma, find the paperwork and file this month. A missed deadline always pays zero.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Always consult with a qualified financial advisor before making investment decisions. Past performance is not indicative of future results.

Share

Written by

Marcus Vance

Business & Money

Writes on business and personal finance for Quick Trend Insights, translating markets, rates, and company strategy into what it costs or saves a household.

More articles

Related Articles

View all